![]() |
市场调查报告书
商品编码
1606550
全球骨科手术机器人市场 - 2024-2031Global Orthopedic Surgical Robots Market - 2024-2031 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
概述
2023年,全球骨科手术机器人市场规模达70亿美元,预计2031年将达到107亿美元,2024-2031年预测期间复合年增长率为5.7%。
骨科手术机器人确实是骨科手术领域的革命性进步,造福病患。骨科手术机器人透过提供高精度、高效率和侵入性的手术,标誌着骨科手术的显着进步,并在改善患者治疗效果方面具有令人难以置信的优势。这些机器人以无与伦比的准确性帮助外科医生执行复杂的手术,而不会因人为错误而降低利润。
由于先进的成像技术、机械手臂和高端软体,它们还为骨切割以及精确的植体放置和对齐提供即时指导。常用手术的例子包括全关节置换、脊椎手术和骨折修復。现在,所有骨科手术机器人都可以透过最小化软组织损伤和优化工作流程来移动患者,以实现更快的康復、更少的併发症和更大的手术成功率。
驱动程式和限制
骨科疾病盛行率上升
骨关节炎、类风湿性关节炎和骨质疏鬆症等骨科疾病发生率的激增,实际上推动了全球骨科手术机器人市场的发展。这些情况与人口的年龄结构或久坐的生活方式无关;它们直接创造了对关节置换和其他骨科干预措施的需求。
使用骨科机器人的实践重点是在膝关节手术中提供精确度和结果,而膝关节手术需要满足大部分要求。机器人替代方案对患者和提供者都有利,因为它们提供更好或改进的对准、更短的恢復时间和更少的併发症。人们越来越依赖机器人协助来减轻日益增加的骨科疾病负担,从而在全球市场上获得更广泛的足迹。
例如,根据澳洲健康与福利研究所2024年的数据,2023年,肌肉骨骼疾病组占总疾病负担的12.8%,占非致命负担的23.1%,占致命负担的0.8%。它是继精神健康状况和药物滥用障碍之后造成非致命负担的第二大疾病组。背部问题是非致命负担的主要原因,占 YLD 的 7.9%。在肌肉骨骼疾病组中,背部问题占负担的 34%,其次是其他肌肉骨骼疾病,占 30%,骨关节炎占 20%,类风湿性关节炎占 16%。
机器人成本高
全球骨科手术机器人市场是由这些先进系统的高成本决定的,其成本可能在 5,500 美元到 10,000 美元以上。这些系统具有精确性、缩短恢復时间和改善手术效果,但实施起来成本高昂,特别是在小型医院和发展中地区。然而,这种财务障碍提供了创新的机会,例如开发具有成本效益的机器人系统或灵活的融资模式,这可以扩大进入并推动市场成长。
Overview
The global orthopedic surgical robots market reached US$ 7.0 billion in 2023 and is expected to reach US$ 10.7 billion by 2031, growing at a CAGR of 5.7% during the forecast period 2024-2031.
Orthopedic surgical robots are indeed revolutionary advances in the field of orthopedic surgery for the benefit of patients. Orthopedic surgical robots mark a considerable improvement in orthopedic surgery by providing surgery with high precision, effectiveness and invasiveness and has incredible advantages to improve patient outcomes. These robots help surgeons with unparalleled accuracy commit to intricate procedures without bringing the margin down due to human error.
They also provide real-time guidance for bone cutting and precise implant placement and alignment, thanks to advanced imaging technologies, robotic arms, and high-end software. Examples of commonly used procedures include total joint replacement, spine surgery, and fracture repairs. All orthopaedic surgical robots through minimal soft tissue damage and optimized workflow can now move a patient for faster recuperation, fewer complications, and greater surgical success.
Market Dynamics: Drivers & Restraints
Rise in the Prevalence of Orthopedic Disorders
The upsurge in the incidence of orthopedic conditions, such as osteoarthritis, rheumatoid arthritis, and osteoporosis, actually drives the global orthopedic surgical robots market. Little do these conditions depend on the age structure or sedentary lifestyle of the population; they directly create demand for joint replacements and other orthopedic interventions.
The practice of using orthopedic robots is focusing on giving precision and outcomes in knee surgeries, where most of the demands are required. Robotic alternatives have been favorable to both the patient and provider because they offer better or improved alignment, lower times of recovery, and fewer complications. There is growing dependence on robotic assistance in alleviating the rising burden of orthopedic disorders, thus attaining a wider footprint in the global market.
For instance, according to Australian Institute of Health and Welfare 2024, In 2023, the musculoskeletal conditions disease group accounted for 12.8% of total disease burden, 23.1% of non-fatal burden, and 0.8% of fatal burden. It was the second leading disease group contributing to non-fatal burden after mental health conditions and substance use disorders. Back problems were the leading cause of non-fatal burden, accounting for 7.9% of YLD. Within the musculoskeletal conditions disease group, back problems accounted for 34% of burden, followed by other musculoskeletal conditions at 30%, osteoarthritis at 20%, and rheumatoid arthritis at 16%.
High Cost of Robots
The global orthopedic surgical robots market is shaped by the high cost of these advanced systems, which can cost between $5,500 and over $10,000. These systems, which offer precision, reduced recovery times, and improved surgical outcomes, are expensive to implement, especially in smaller hospitals and developing regions. However, this financial barrier presents opportunities for innovation, such as developing cost-effective robotic systems or flexible financing models, which could broaden access and drive market growth.
The global orthopedic surgical robots market is segmented based on product type, application, end user and region.
Systems segment is expected to dominate the orthopedic surgical robots market share
The systems segment holds a major portion of the orthopedic surgical robots market share and is expected to continue to hold a significant portion of the orthopedic surgical robots market share during the forecast period.
Orthopedic surgical systems are revolutionizing the global market by providing precise alignment, accurate bone resection, and improved implant placement in procedures like joint replacements and spine surgeries. These systems, equipped with advanced imaging, navigation, and robotic-assisted technologies, minimize human error, enhance surgical consistency, and contribute to better patient outcomes, reduced complications, and faster recovery times. As technological advancements continue, orthopedic surgical systems are expected to remain at the forefront of innovation, driving market growth by offering enhanced capabilities tailored to complex orthopedic procedures.
For instance, in October 2024, Aradhana Orthopedic Hospital in Shivamogga has introduced the region's first fully automatic robotic system for knee replacement surgeries, led by Dr. Girish Kumar K., MBBS, MS. This technology offers precision, efficiency, and quicker recovery times for patients undergoing knee replacement surgeries.
Spine Surgery segment is the fastest-growing segment in orthopedic surgical robots market share
The spine surgery segment is the fastest-growing segment in the orthopedic surgical robots market share and is expected to hold the market share over the forecast period.
Spine surgery is driving the global orthopedic surgical robots market growth, as robotic systems improve precision and safety in complex procedures like spinal fusions and decompressions. Advanced imaging and navigation technologies create accurate surgical plans, reducing complications and improving patient outcomes. The demand for robotic assistance in spine surgeries is driven by the increasing prevalence of spinal disorders, an aging population, and awareness of minimally invasive techniques. Robotic systems are reshaping the spine surgery landscape, making them a key segment in the orthopedic surgical robots market.
For instance, in August 2024, Johnson & Johnson MedTech has announced the launch of the VELYS Active Robotic-Assisted System (VELYS SPINE), a dual-use robotics and standalone navigation platform developed in collaboration with eCential Robotics. The system, which has received FDA clearance, is intended for spinal fusion procedures in the cervical, thoracolumbar, and sacroiliac spine. The dual-use system offers surgeons flexibility in their approach and plans, with active robotics allowing for surgical guidance tailored to their preferences. The unique features of active robotics technology are expected to set a new standard in spine surgical care.
North America is expected to hold a significant position in the orthopedic surgical robots market share
North America holds a substantial position in the orthopaedic surgical robots' market and is expected to hold most of the market share.
North America is a major player in the global orthopaedic surgical robots' market due to technological advancements, robust healthcare infrastructure, and substantial financial investments. The region's network of hospitals and surgical centers prioritizes cutting-edge technologies, leading to widespread acceptance of robotic-assisted surgeries for joint replacements and spine surgeries. The high prevalence of musculoskeletal disorders, such as osteoarthritis and degenerative spine conditions, further fuels the demand for robotic-assisted surgeries.
Moreover, North America's leading manufacturers and innovators in robotic surgery systems drive the market forward, while favourable reimbursement policies and ongoing training of surgeons contribute to its dominance. The trend towards minimally invasive surgeries ensures the continued growth of orthopaedic surgical robots in the region.
For instance, in November 2024, THINK Surgical has received FDA clearance for its TMINI Miniature Robotic System, which is used with LinkSymphoKnee from Waldemar Link GmbH & Co. KG, Germany, under a collaboration agreement. The LinkSymphoKnee is part of THINK Surgical's ID-HUB, a proprietary data bank for the open platform version of its TMINI System in the US.
Europe is growing at the fastest pace in the orthopedic surgical robots market
Europe holds the fastest pace in the orthopaedic surgical robots market and is expected to hold most of the market share.
Europe is a key player in the global orthopaedic surgical robots' market, driven by advanced healthcare systems, innovative technologies, and a focus on surgical precision. The region's supportive regulatory framework and reimbursement structures encourage the integration of robotics in surgical procedures. The aging population, more susceptible to orthopaedic conditions like osteoporosis and joint degeneration, drives the demand for surgical interventions. European healthcare providers are investing in robotic systems to enhance accuracy, reduce complications, and meet minimally invasive procedures. Countries like Germany, the UK, and France are leading the charge, with high adoption rates of robotic-assisted surgeries.
For instance, in September 2024, ZEISS Medical Technology has introduced the KINEVO 900 S, a new Robotic Visualization System, which enhances the clarity of complex surgical procedures in neurosurgery and other surgical disciplines, incorporating advanced digital visualization, collaborative assistant functions, and connected intelligence.
Moreover, in October 2024, Hospital Clinic Barcelona has performed 530 robotic knee replacement surgeries in three and a half years, using the ROSA robot developed by Zimmer and the Smith Nephew CORI Surgical System in 2022. This technological advancement enhances precision, safety, and patient recovery, making it the most performed hospital in Spain. The hospital's use of robotic surgery has minimized risks.
The major global players in the orthopedic surgical robots market include Ekso Bionics, Intuitive Surgical, Medtronic, Stryker Corporation, Smith & Nephew, Wright Medical Group N. V, Zimmer Biomet, General Electric, Think Surgical Inc, Omni among others.
Emerging Players
The emerging players in the orthopedic surgical robots market include Adamis Robotics, OMNIlife Science, Inc, Medicaroid Corporation, Monogram Orthopedics and among others
The global orthopedic surgical robots market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE